awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34510030-0D393B33-04E0-4CBB-8545-477E711C0638
Q34510030-0D393B33-04E0-4CBB-8545-477E711C0638
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34510030-0D393B33-04E0-4CBB-8545-477E711C0638
The spectrum of use of rituximab in chronic lymphocytic leukemia
P2860
Q34510030-0D393B33-04E0-4CBB-8545-477E711C0638
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34510030-0D393B33-04E0-4CBB-8545-477E711C0638
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b10f330304f4d1105a4874e83f2a1dca17de1437
P2860
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).